Kwangdong Pharmaceutical says Chairman Choi Sung-won keeps 19.42% stake after contract extension disclosure

• Choi Seong-won filed an amended major-shareholding report in Kwangdong Pharmaceutical, citing an extension of share-pledge contracts.
• Total holdings were unchanged at 9,670,292 shares, equal to 19.42% as of Oct. 12, 2026.
• Shares under key contracts were unchanged at 1,486,560 shares, equal to 2.99%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kwangdong Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012000431), on October 12, 2026, and is solely responsible for the information contained therein.